Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mace Rothenberg Insider Profile
4 Followers
Mace Rothenberg, Director at Surrozen, holds ― shares in Surrozen (Ticker: SRZN), holds 11.25K shares in Tango Therapeutics (Ticker: TNGX). Most recently, Mace Rothenberg ― shares of Surrozen on ― for an estimated value of ―.
Mace Rothenberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mace Rothenberg holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mace Rothenberg
Mace Rothenberg's Trading History
Surrozen
―
Director
―
―
Tango Therapeutics
Jun 07, 2024
Director
Uninformative Buy
―
$93.83K
List of latest transactions for each holding click on a transaction to see Mace Rothenberg's performance on stock
You May Also Like
Mace Rothenberg insider profile FAQ
What is the percentage of profitable transactions made by Mace Rothenberg?
The percentage of profitable transactions made by Mace Rothenberg is ―.
What is the average return per transaction made by Mace Rothenberg?
The average return per transaction made by Mace Rothenberg is ―.
What stocks does Mace Rothenberg hold?
Mace Rothenberg holds: SRZN, TNGX stocks.
What was Mace Rothenberg’s latest transaction?
Mace Rothenberg latest transaction was an Uninformative Buy of ―.
What was Mace Rothenberg's most profitable transaction?
Mace Rothenberg’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mace Rothenberg's role in Surrozen?
Mace Rothenberg's role in Surrozen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.